— GROWTH PARTNER FOR PEPTIDE BRANDS

OUR GROWTH SYSTEM TAKES PEPTIDE BRANDS TO $500K/MONTH.

We scale peptide brands on Google Ads and build the retention engine that compounds around it.

We scale peptide brands on Google Ads and build the retention engine that compounds around it.

One client went from $0 to $500K/month in 4 months – acquisition, email, and the operational playbook that makes it all survive the platform risks unique to this niche

$1M+

Monthly revenue managed for peptide stores

$400K+

Monthly peptides ad spend revenue managed

3

Marketing channels managed

— 01 · THE OPPORTUNITY

A $140B CATEGORY.

And almost NO ONE running it right.

Peptide therapeutics is a $140B+ category growing 8–10% a year. North America is 62% of it.

The demand is real, the intent is high, and the buyers are actively searching.

The winners in this niche aren't the brands with the best product - they're the brands that figured out how to actually market it.

Most don't.

They run Meta until the account gets disabled, then spin up a burner and start over.

They build email on Klaviyo and pray compliance doesn't review them.

They treat Google like an afterthought because nobody on their team knows how to navigate Merchant Center for this category.
Meanwhile, the brands doing it right are compounding.

Google Ads running consistently at scale.

Owned email infrastructure. A retention engine that prints revenue 24/7.

That's what a peptide growth system actually looks like - and it's what separates the brands scaling past $500K/month from the ones stuck cycling burner accounts.

Stop playing defense. Start compounding.

— 02 · THE OPERATIONAL LAYER

THE SYSTEM THAT ACTUALLY SCALES PEPTIDE BRANDS.

This isn't about "running Google Ads." Any agency can set up a PMax campaign.

What most can't do is this:

This isn't about "running Google Ads." Any agency can set up a PMax campaign.
What most can't do is this:

PILLAR 01

Google Merchant Center

Where the battle is actually won.

Shopping and PMax are the workhorses for peptide brands on Google – but only if your products are approved in Merchant Center. No approval, no Shopping, no PMax.

Most peptide disapprovals aren’t about peptides.

They’re technical: wrong category, missing GTIN, feed mismatches, image spec issues, or shipping policy gaps.

Last week, three people on our team spent an hour getting a single product approved. One product. One hour. Three people. That’s the moat – most agencies won’t.

PILLAR 02

Shopping + PMax Architecture

The campaign stack that scaled a brand to $303K/mo.

Shopping builds the data foundation – someone searching “BPC-157 5mg” knows exactly what they want, and Shopping puts your product in front of them at the moment of intent.

Once conversion data flows, PMax scales that signal across Google’s network, while Search captures branded and long-tail terms.

~60% Shopping + PMax · ~20% Search · ~20% Testing. Daily budget increases capped at 10–15% – never shock the algorithm.

PILLAR 03

Compliant Creative

What you can’t show — and what still converts.

Peptide images on Google follow strict rules: no vials with syringes, no humans, no text overlays implying human use, and no health claims anywhere on the landing page.

 

What works: clean product photography on neutral backgrounds, research-grade positioning, and PMax asset groups built with compliant headlines like “research peptide” or “laboratory grade” – never therapeutic claims.

For Meta (post-MEDVi): trust-based, science-led creative. Third-party testing, research-first framing. Compliance isn’t optional.

PILLAR 04

Owned Email Infrastructure

When your ESP bans you mid-scale, you need a playbook.

We build the full retention stack: Welcome, Checkout and Browse Abandonment, Post-Purchase, VIP, Winback, and Replenishment tuned to 20–50 day reorder cycles.

 

When Klaviyo shut an account down mid-scale, we migrated to FluentCRM on WooCommerce and rebuilt every flow in 2–3 weeks – automation revenue recovered quickly.

New default: if you’re in a regulated niche, don’t build on rented land. Own your infrastructure. Every SaaS ESP can pull the plug.

—04 · THE 90-DAY REALITY

WHAT THE FIRST 90 DAYS ACTUALLY LOOK LIKE.

We don't promise hockey-stick growth in week two.

Here's the honest operating timeline - drawn from our peptide engagements, including the client who went from $0 to $500K/month in 4 months.

PHASE 01 · Days 1–30
Foundation. Expect to lose money.

Merchant Center cleanup and product approval. Tracking integrity (GA4, conversion tags). First Shopping and PMax campaigns on limited budget to feed the algorithm. Email infrastructure decisions — we default to self-hosted for peptides now. Foundational flows live.

REALISTIC EXPECTATION

$7K in ad spend returned ~$4.5K in revenue for our case study client. Budget 30–60 days of algorithm learning. Brands that panic here never make it to profitability.

PHASE 02 · Days 31–60
Signal and scale.

Algorithm finds conversion patterns. Shopping pulls. PMax gets enough data to scale. Winning product categories identified, underperformers killed, search terms refined. Email flows generating consistent automated revenue. Meta launch prep with post-MEDVi positioning.

REALISTIC EXPECTATION
~$14K/month revenue range on a similar spend profile. Profitable, not yet at scale. Full post-purchase and Winback flows live.

PHASE 03 · Days 61–90
The scaling curve.

10–15% daily budget increases on winning PMax campaigns. Meta running compliant creative at scale. Replenishment catching reorders. VIP and Winback layered in. Any platform disruption handled without losing momentum.

CASE STUDY TRAJECTORY
$170K/mo by Month 3. $500K/mo peak by Month 4. Your numbers will differ. The system behind them is the same.

—04 · DEEP CASE STUDY

ONE BRAND.
ZERO TO $500K/MONTH.
FOUR MONTHS.

— 05 · FIT FILTER

WHO WE WORK WITH IN THIS NICHE.

GOOD FIT

Owners who understand that Month 1-2 on ads is an investment, not an instant returns.

Credict card payment processing already setup.

Founders and teams willing to operate inside compliance constraints on creative, landing page, and language.

Stores that want a partner handling scaling and retention together – not a vendor running one channel in isolation.

Willing to self-host email infrastructure. 

NOT A FIT

Brands looking for the cheapest possible execution.

Owners who cut ad budget the first week ROAS dips below 1.0.

Teams that want to run aggressive therapeutic claims or human-use marketing (we will not help you).

Brands with no payment processing in place, or on processors likely to drop peptide merchants.

Anyone looking for a “just run Meta ads” engagement – that’s a treadmill, not a strategy.

— 06 · OBJECTIONS

WHAT PEPTIDE BRAND OWNERS ASK US ON EVERY CALL.

Yes, with constraints. After the MEDVi enforcement wave in early 2026, Meta tightened aggressively across the category. We run Meta with research-first positioning, trust-based and science-led creative, no therapeutic claims, and disciplined account hygiene. We’ve held 7–25× ROAS on Meta for peptide clients operating this way. We won’t run burner-account strategies — that’s not marketing, it’s a ban clock.

When, not if. We default to self-hosted email infrastructure (FluentCRM on WooCommerce, or equivalent stacks on Shopify) for peptide brands from day one now. We’ve done the emergency migration once — we’d rather skip it for you. If you’re already on Klaviyo and working, we can build a migration path that doesn’t disrupt revenue.

For Google ads from scratch, expect to spend $3K+ in Month 1 primarily on algorithm learning, with revenue lagging spend. If that number isn’t realistic, we’re not the right fit yet. By Month 3, budgets scale with performance — the brands that make it past the foundational 60 days typically run $50K+/month profitably.

Happens in this category. We’ve handled a domain migration mid-scale without dropping revenue — the system is built to absorb that kind of disruption. We don’t run payment processing, but we coordinate with your team through the cutover: ad accounts, tracking, email links, Merchant Center feed updates.

Based on our case study client: Month 1 negative, Month 2 break-even to modestly profitable, Month 3 first significant revenue (~$170K range on that trajectory), peak at Month 4. Your numbers will differ based on product mix, traffic baseline, and starting state. The pattern — algorithm learning, signal discovery, controlled scale — is consistent.

— 07 · LET’S TALK

READY TO BUILD A PEPTIDE BRAND THAT ACTUALLY COMPOUNDS?

If you’re running a US or EU peptide brand with real product demand and you want a team that knows this category at an operational level -Merchant Center, compliant creative, self-hosted email, the full stack – request a call.

You’ll talk to Daniel directly.

No sales rep, no gatekeeping. First call is a 30-minute strategy conversation: we’ll review your current state, identify the biggest leaks, and tell you honestly whether we’re the right partner.

If we’re not, we’ll point you in the right direction.

A NOTE FROM DANIEL

I built Budai Media to be the agency I always wished existed: one that treats your brand with the same care and strategic thinking as if it were our own.
 
Too many agencies focus on deliverables rather than results. We focus on growth—yours and ours together. That’s why we cap our client roster at 20, why we only hire senior experts, and why our average client stays with us for 12+ months.
 
Your success is our mission, and we won’t stop until your business is thriving because of our work.
 
— Daniel Budai, Founder